A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers

Clinical trial NCT01521325 · COMPLETED

Trial details

NCT number: NCT01521325
Sponsor: Morphotek
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Mesothelioma Pancreatic Cancer Ovarian Cancer Non-small Cell Lung Cancer

Start date: 2011-09-01
Primary completion: 2013-03-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.